LifeStance Health (LFST) Gains from Investment Securities (2021 - 2025)
LifeStance Health (LFST) has disclosed Gains from Investment Securities for 5 consecutive years, with $10.1 million as the latest value for Q4 2025.
- Quarterly Gains from Investment Securities changed N/A to $10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.8 million through Dec 2025, up 42.6% year-over-year, with the annual reading at $13.7 million for FY2024, 1.45% up from the prior year.
- Gains from Investment Securities for Q4 2025 was $10.1 million at LifeStance Health, down from $12.6 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $47.0 million in Q2 2021, with the low at -$357000.0 in Q1 2025.
- Average Gains from Investment Securities over 5 years is $6.5 million, with a median of $305000.0 recorded in 2021.
- The sharpest move saw Gains from Investment Securities plummeted 99.9% in 2022, then surged 101347.02% in 2024.
- Over 5 years, Gains from Investment Securities stood at $530000.0 in 2021, then soared by 231.89% to $1.8 million in 2022, then skyrocketed by 190.22% to $5.1 million in 2023, then soared by 167.8% to $13.7 million in 2024, then decreased by 25.79% to $10.1 million in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods came in at $10.1 million, $12.6 million, and -$357000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.